Alberta Investment Management Corporation »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alberta Investment Management Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Alberta Investment Management Corporation from 13F filings

Historical chart of Alberta Investment Management Corporation investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Alberta Investment Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Alberta Investment Management Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $47M 35M 1.33
2025-03-31 $13M 10M 1.28

More positions owned by Alberta Investment Management Corporation

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Western Digital Corp Note 3.000%11/1 (Principal)
Agnico (AEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)
Bank Of Montreal Cadcom (BMO)
Interdigital Note 3.500% 6/0 (Principal)
Bk Nova Cad (BNS)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)

View all positions for Alberta Investment Management Corporation

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
Point72 Asset Management
LMR Partners
Balyasny Asset Management
Alberta Investment Management Corporation
Jain Global
Jpmorgan Chase & Co
Lazard Asset Management
Lombard Odier Asset Management
Absolute Investment Advisers
Citadel Advisors
Linden Advisors
Calamos Advisors
Tenor Capital Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1